Controlled release and angiotensin-converting enzyme inhibition properties of an antihypertensive drug based on a perindopril erbumine-layered double hydroxide nanocomposite.
The intercalation of perindopril erbumine into Zn/Al-NO3-layered double hydroxide resulted in the formation of a host-guest type of material. By virtue of the ionexchange properties of layered double hydroxide, perindopril erbumine was released in a sustained manner. Therefore, this intercalated mat...
Main Authors: | Hussein Al Ali, Samer Hasan, Al-Qubaisi, Mothanna, Hussein, Mohd Zobir, Ismail, Maznah, Zainal, Zulkarnain, Abdullah, Muhammad Nazrul Hakim |
---|---|
Format: | Article |
Language: | English English |
Published: |
Dove Medical Press
2012
|
Online Access: | http://psasir.upm.edu.my/id/eprint/24618/1/Controlled%20release%20and%20angiotensin.pdf |
Similar Items
-
Perindopril erbumine-layered double hydroxide nanocomposite as a controlled release formulation of an anti hypertensive drug
by: Hussein, Mohd Zobir, et al.
Published: (2012) -
Preparation of ellagic acid, huppuric acid, perindopril erbumine and cetirizine nanocomposites for drug delivery
by: Ahmad Hussein Al Ali, Samer Hasan
Published: (2012) -
Preparation of chitosan nanoparticles as a drug delivery system for perindopril erbumine
by: Hussein-Al-Ali, Samer Hasan, et al.
Published: (2018) -
Hippurate-Zinc layered Hydroxide Nanohybrid and its synergistic effect with Tamoxifen on the HepG2 cell lines.
by: Hussein, Mohd. Zobir, et al.
Published: (2011) -
Controlled-release formulation of perindopril erbumine loaded PEG-coated magnetite nanoparticles for biomedical applications
by: Dorniani, Dena, et al.
Published: (2014)